PEAK6 Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

PEAK6 Group’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$52K	Sell	624 -838	-57%	-$61.4K	﹤0.01%	3916
2018 Q1	$90K	Sell	1,462 -11,320	-89%	-$682K	﹤0.01%	3766
2017 Q4	$747K	Sell	12,782 -6,238	-33%	-$393K	﹤0.01%	2152
2017 Q3	$1.1M	Buy	19,020 +11,405	+150%	+$1.23M	0.01%	1885
2017 Q2	$922K	Sell	7,615 -576	-7%	-$66.7K	0.01%	1996
2017 Q1	$926K	Sell	8,191 -1,015	-11%	-$118K	0.01%	1745
2016 Q4	$1M	Buy	9,206 +6,191	+205%	+$738K	0.01%	1870
2016 Q3	$496K	Buy	+3,015	New	+$475K	﹤0.01%	2359
2016 Q1	–	Sell	-5,200	Closed	-$777K	–	5190
2015 Q4	$777K	Buy	5,200 +2,100	+68%	+$355K	0.01%	2175
2015 Q3	$514K	Buy	3,100 +2,100	+210%	+$462K	﹤0.01%	2860
2015 Q2	$241K	Buy	+1,000	New	+$266K	﹤0.01%	3545
2014 Q3	–	Sell	-3,100	Closed	-$790K	–	5304
2014 Q2	$734K	Buy	3,100 +3,000	+3,000%	+$791K	0.01%	1935
2014 Q1	$33K	Buy	+100	New	+$33.7K	﹤0.01%	4444

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

PEAK6 Group's ICPT Position: Q2 2018 in Review

PEAK6 Group reduced its Intercept Pharmaceuticals, Inc. (ICPT) stake by 57% in Q2 2018, selling an estimated $61.4K and leaving 624 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #3916.

PEAK6 Group first reported a position in ICPT in Q1 2014 and has held it in 13 quarters since. The position peaked at $1.1M in Q3 2017. 163 funds tracked by Wall St. Rank hold ICPT as of Q2 2018.

PEAK6 Group held 624 shares of Intercept Pharmaceuticals, Inc. worth $52K as of Q2 2018.
PEAK6 Group sold 838 Intercept Pharmaceuticals, Inc. shares in Q2 2018, an estimated $61.4K.
Intercept Pharmaceuticals, Inc. made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3916 holding.
PEAK6 Group first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and has held it in 13 quarters since.
PEAK6 Group's Intercept Pharmaceuticals, Inc. position peaked at $1.1M in Q3 2017.
163 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.